Clicky

23andMe Holding Co.(ME)

Description: 23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.


Keywords: Biology Drug Development Genomics Genetics Medical Genetics Applied Genetics Genetic Testing Human Genome

Home Page: www.23andme.com

ME Technical Analysis

349 Oyster Point Boulevard
South San Francisco, CA 94080
United States
Phone: 650 938 6300


Officers

Name Title
Ms. Anne Wojcicki Co-Founder, CEO, Pres & Director
Ms. Kathy L. Hibbs Esq., J.D. Chief Admin. Officer and Sec.
Dr. Kenneth J. Hillan Ch.B., M.B. Chief Therapeutics Officer
Mr. Joseph Selsavage Interim CFO & Accounting Officer
Dr. Joseph R. Arron M.D., Ph.D. Chief Scientific Officer
Dr. Wade Walke VP of Investor Relations
Ms. Jacquie Cooke Haggarty J.D. Gen. Counsel & Privacy Officer
Ms. Katie Watson VP of Communications
Mr. Jonathan Ward Chief Marketing Officer
Ms. Savita Pillai VP of People

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.7123
Price-to-Sales TTM: 4.1168
IPO Date: 2020-11-23
Fiscal Year End: March
Full Time Employees: 0
Back to stocks